Funding for this research was provided by:
Fondazione Umberto Veronesi
Breast Cancer Now
Oxford NIHR Biomedical Research Centre Kennington Cancer Fund
Received: 10 May 2020
Revised: 10 September 2020
Accepted: 17 September 2020
First Online: 8 October 2020
Ethics approval and consent to participate
: This work obtained ethics approval by the North West-Greater Manchester Central Research Ethics Committee under the title: Nottingham Health Science Biobank (NHSB), reference number 15/NW/0685. All patients included were consented to participate in the study and to use their materials in research. All samples from Nottingham used in this study were pseudo-anonymised and stored in compliance with the UK Human Tissue Act. The study was performed in accordance with the Declaration of Helsinki
: Not applicable.
: The data presented in the current study are available upon reasonable request from the corresponding author.
: The authors declare no competing interests.
: This research was supported by funding from Cancer Research UK (C19591/A19076; D.C.I.G.), Oxford NIHR Biomedical Research Centre, Breast Cancer Research Foundation (A.L.H.), Kennington Cancer Fund (A.L.H.) and by a Fondazione Veronesi fellowship (to M.M.).